(AOF) – Bastide announces that it has been designated by the NHS (National Health Service) as the exclusive operator in respiratory assistance (oxygen therapy) for the East of England region in the United Kingdom. This new contract, lasting 7 years, extendable to 10 years, will bring additional turnover of around 10 million euros per year. The Bastide group will begin operating in this region before the end of 2024, once the administrative and legal phase has been finalized.
Baywater Healthcare is now the exclusive operator in 5 of the 11 UK regions (East of England, North West, West Midlands, Wales, Yorkshire).
Bastide has been present in the United Kingdom in the home respiratory assistance market since the acquisition of Baywater Healthcare in 2018.
This coverage could further expand with the London region, the allocation of which is expected soon, and for which the group had been designated, before the recourse of the operator currently in place.
The French group is consolidating its position as the leading local player, with more than 37,000 patients now receiving oxygen therapy and an annual turnover of around 50 million euros over the full year.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
